How we approach it: treatment options for hepatocellular carcinoma

Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.

Authors

Ruben Hernaez^{1

1

1}, Hashem B El-Serag^{1

1

1}

Affiliation

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

PMID: 29713029
DOI: 10.1038/s41395-018-0008-9

No abstract available

MeSH terms

Ablation Techniques / adverse effects
Ablation Techniques / methods
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects
Biopsy
Carcinoma, Hepatocellular / diagnosis
Carcinoma, Hepatocellular / epidemiology
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / therapy*
Chemoembolization, Therapeutic / adverse effects
Chemoembolization, Therapeutic / methods
Humans
Immunotherapy / methods
Incidence
Liver / pathology
Liver / surgery
Liver Neoplasms / diagnosis
Liver Neoplasms / epidemiology
Liver Neoplasms / pathology
Liver Neoplasms / therapy*
Liver Transplantation
Palliative Care / methods
Patient Care Team / organization & administration
Radiosurgery / methods
United States / epidemiology

Substances

Antineoplastic Agents